SEC Info - BioCardia, Inc. - ‘CORRESP’ from 6/15/20

SEC Info℠

Home

Help

Please Sign In

BioCardia, Inc. – ‘CORRESP’ from 6/15/20

On: Monday, 6/15/20, at 8:29am ET · Delayed-Release: Filing `¶` – Release Delayed to: 7/15/20 · Accession #: 1437749-20-13085

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/15/20  BioCardia, Inc.                   CORRESP¶    7/15/20    1:13K                                    RDG Filings/FA

Delayed-Release Comment-Response or Other Letter to the SEC
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: CORRESP     Comment-Response or Other Letter to the SEC         HTML     10K

This is an HTML Document rendered as filed. [ Alternative Formats ]

bcda20200614_corresp.htm

C: <> <>

June 15, 2020

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549-3720

Attention: Ada D. Sarmento

Re:	BioCardia, Inc. Registration Statement on Form S-1 Filed on June 15, 2020 File No. 333-236404

Acceleration Request
Requested Date: June 16, 2020
Requested Time: 5:00 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-236404) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request via telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”). The Company hereby authorizes Nathan Robinson of Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel for the Company, to make such request on the Company’s behalf.

The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Nathan Robinson of Wilson Sonsini Goodrich & Rosati, Professional Corporation at (512) 418-6483 or via email at nrobinson@wsgr.com. If notice of effectiveness is given by telephone, please also provide a copy of the Commission’s order declaring the Registration Statement effective to Nathan Robinson via facsimile at (512) 338-5499.

Please direct any questions or comments regarding this acceleration request to Nathan Robinson at (512) 418-6483.

		Sincerely,

		BIOCARDIA, INC.


		By:		/s/ *David McClung*
				David McClung
				Chief Financial Officer

Dates Referenced Herein and Documents Incorporated by Reference

This ‘CORRESP’ Filing	Date	Other Filings

Release Delayed to:	7/15/20	UPLOAD
Filed on:	6/15/20	CORRESP, S-1/A
		List all Filings

↑Top

Filing Submission 0001437749-20-013085 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

BioCardia, Inc. – ‘CORRESP’ from 6/15/20

On: Monday, 6/15/20, at 8:29am ET · Delayed-Release: Filing ¶ – Release Delayed to: 7/15/20 · Accession #: 1437749-20-13085

Previous ‘CORRESP’: ‘CORRESP’ on 12/5/19 · Next: ‘CORRESP’ on 6/15/20 · Latest: ‘CORRESP’ on 12/1/23

Delayed-Release Comment-Response or Other Letter to the SECFiling Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

On: Monday, 6/15/20, at 8:29am ET · Delayed-Release: Filing `¶` – Release Delayed to: 7/15/20 · Accession #: 1437749-20-13085

Delayed-Release Comment-Response or Other Letter to the SEC
Filing Table of Contents